IQVIA Holdings Inc.
IQV
Kedudukan dalam Saham
#556
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical... IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Harga Saham
$268.66
Modal Pasaran
$44.22B
Perubahan (1 hari)
1.05%
Perubahan (1 tahun)
26.70%
Negara
US
Perdagangan IQVIA Holdings Inc. (IQV)
Kategori
Healthcare
Pendapatan untuk IQVIA Holdings Inc. (IQV)
Pendapatan pada Jun 2026 TTM: $1.61B
Menurut laporan kewangan terkini IQVIA Holdings Inc., pendapatan semasa syarikat ialah $1.61B. Pada tahun 2024, syarikat memperoleh pendapatan sebanyak $1.67B, peningkatan berbanding pendapatan pada tahun 2023 yang berjumlah $1.46B. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi IQVIA Holdings Inc. dari 2010 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Ubah |
|---|---|---|
| 2026 (TTM) | $1.61B | -0.25% |
| 2025 | $1.61B | -3.36% |
| 2024 | $1.67B | 14.39% |
| 2023 | $1.46B | 7.99% |
| 2022 | $1.35B | 19.14% |
| 2021 | $1.13B | 198.42% |
| 2020 | $380.00M | 10.79% |
| 2019 | $343.00M | 0.00% |
| 2018 | $343.00M | 12.83% |
| 2017 | $304.00M | -26.21% |
| 2016 | $412.00M | -24.68% |
| 2015 | $547.00M | 8.10% |
| 2014 | $506.00M | 56.60% |
| 2013 | $323.12M | 19.67% |
| 2012 | $270.00M | 5.70% |
| 2011 | $255.43M | 5.67% |
| 2010 | $241.73M | 0.00% |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| $7.61B | 372.90% |
US
|
|
| $4.76B | 195.96% |
US
|
|
| $-252.70M | -115.71% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 3.05% |
US
|
